Celldex (CLDX) Announces Presentation of Encouraging CDX-1140 Data in Hematologic and Solid Malignancies
Tweet Send to a Friend
Celldex Therapeutics, Inc. (Nasdaq: CLDX) presented data on new product candidate CDX-1140, a fully human antibody targeted to CD40 that ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
